Next week, Atul Gawande, the prominent author, surgeon, researcher, and—most recently—presidential nominee to lead USAID’s Bureau for Global Health, will appear before the Senate Foreign Relations Committee for his nomination hearing to serve as Assistant Administrator.
CGD Policy Blogs
Germany has stepped up as an important player in global health in recent years, rising to become the third largest government donor to health in 2019. Notably, Germany has played a key role in WHO reform efforts; it is the largest donor to WHO for the 2020-21 budget period, and one of the largest WHO emergency fund donors. Germany has also played a leading role politically, placing health on the agenda of the G-20 for the first time in 2017 and trying to tackle increasing global health fragmentation as co-initiator of the Global Action Plan.
Aligning the Researcher’s Toolkit with the Policymaker’s Priorities: A Menu of Strategies for Faster, Lower-Cost Impact Evaluations
As the COVID-19 pandemic continues to rage and public funding is increasingly scarce, the need for high-quality, timely evidence on the effectiveness of public programs has never been clearer. In this blog, we share a top-line summary of the methodological and data advances alongside recommendations for how to harness their potential to move the field forward. And on September 29, we’ll host Isaksson and other speakers for a CGD seminar to discuss the paper and related topics in more detail—we hope you’ll join us.
Today, we are excited to launch a background paper by our colleague Abeba Taddese that explores how these partnerships work, barriers that hinder progress, and ideas for what funders can do to help advance partnership models (alongside a complementary piece focused on rapid rigorous evaluations). The paper, based primarily on desk research supplemented with expert interviews, is not meant to be an exhaustive review of all partnership models, but to examine illustrative examples and draw out insights that could be useful for rethinking how development funders channel support going forward.
The early days of the US International Development Finance Corporation (DFC) have been defined by a mixed record, and its health-focused investments are no exception. In the face of competing foreign (and even domestic) policy priorities under the Trump Administration and pandemic-related shifts in the broader development landscape, the agency has struggled to build a solid pipeline of projects in lower-income markets and systematically articulate a strong development rationale for its financing.
The UK Aid Cuts to UNFPA: Ripple Effects in Sexual and Reproductive Health Product Markets with Outsized Impacts for Women and Girls
The UN Population Fund (UNFPA) recently revealed that the UK government intends to cut aid to its supplies program by 85 percent, slashing Britain’s original 2021 commitment from $211 million to $32 million.
COVID-19 Vaccination and the Multilateral Development Banks: Moving Towards a More Systematic and Strategic Approach
How should the MDB vaccine effort intersect with global efforts like COVAX, or indeed plans to share or donate vaccine amongst countries? In this blog, we look at two issues raised by the World Bank’s approach so far and offer options for a better way forward.
Getting Back on Track: How to Advance the Biden-Harris Administration’s Early Actions on Women’s Health
Here are four additional policy priorities for the Biden-Harris administration’s to-do list.
If governments of LMICs reformed their medicines procurement practices, how much money would they be able to save? And how much further towards universal health coverage would these savings enable them to go?